Mr. Maduck was named Corcept’s President of Endocrinology in 2022. He previously held positions of increasing seniority in the Commercial organization, most recently serving as Senior Vice President and Chief Commercial Officer. Mr. Maduck joined Corcept in 2012, bringing to the company 12 years of pharmaceutical, biotechnology and management experience. From 2002 to 2012, he held positions in the Finance, Portfolio Planning and Commercial functions at Genentech. Prior to Genentech, he was an investment banking analyst at W.R. Hambrecht + Company. He currently serves on the Board of Directors of the Cancer Support Community – San Francisco Bay Area. Mr. Maduck earned an AB from Dartmouth College, a BE in Biomedical Engineering from the Thayer School of Engineering at Dartmouth College and a Masters in Management from the Stanford Graduate School of Business.